Variability in Diagnosis and Treatment of Recurrent IgA Nephropathy in Kidney Transplants: Results of Surveys of Renal Pathologists and Nephrologists

Haas Mark

首页> 外文期刊>kidney international reports >Variability in Diagnosis and Treatment of Recurrent IgA Nephropathy in Kidney Transplants: Results of Surveys of Renal Pathologists and Nephrologists

【24h】

Variability in Diagnosis and Treatment of Recurrent IgA Nephropathy in Kidney Transplants: Results of Surveys of Renal Pathologists and Nephrologists

机译：肾移植复发性 IgA 肾病诊断和治疗的变异性：肾脏病理学家和肾病学家的调查结果

获取原文

获取原文并翻译 | 示例

开具论文收录证明 >>

AI期刊论文写作 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《kidney international reports》 |2023年第11期|2486-2487|共2页
作者
Haas Mark;
展开▼
作者单位

Cedars Sinai Med Ctr;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类
关键词
IgA nephropathy; kidney transplantation; recurrent glomerulonephritis;

机译：IgA肾病;肾移植;复发性肾小球肾炎;

相似文献

外文文献
中文文献
专利

1. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. [J] . Moriyama T, Nitta K, Suzuki K, Clinical transplantation. . 2005,第14期

机译：来自供体肾脏的潜在IgA沉积是肾脏移植中复发性IgA肾病的主要危险因素。
2. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. [J] . Moriyama T, Nitta K, Suzuki KHonda KHorita SUchida KYumura WTanabe KToma HNihei HYamaguchi Y Clinical transplantation . 2005,第14期

机译：供体肾脏的潜伏性 IgA 沉积是肾移植中复发性 IgA 肾病的主要危险因素。
3. Successful treatment of nephrotic syndrome caused by recurrent IgA nephropathy with chronic active antibody-mediated rejection three years after kidney transplantation. [J] . Yaginuma T, Yamamoto H, Mitome J, Clinical transplantation. . 2011,第23期

机译：肾移植三年后，以慢性活性抗体介导的排斥反应成功治疗了复发性IgA肾病引起的肾病综合征。
4. Clinical Observation of 29 Cases of Tonifying Kidney and Spleen, Detoxification of Throat Traditional Chinese Medicine in the Treatment of IgA Nephropathy [C] . Di ZOU, Hong-an WANG, Yin-ping WANG, International Conference on Biomedical and Biological Engineering . 2016

机译：肾脏和脾脏调整29例临床观察，咽喉中医解毒治疗IgA肾病
5. A Retrospective Analysis of Renal Transplant Outcomes: induction Immunosuppression with Anti-thymocyte Globulin vs. Alemtuzumab in patients undergoing Deceased and Living Donor Kidney Transplantation. [D] . DiMartino, Debra A. 2012

机译：肾移植结果的回顾性分析：死者和活体供者肾脏移植患者中抗胸腺细胞球蛋白与Alemtuzumab的诱导免疫抑制作用。
6. Nephrologists’ Perceptions of Renal Transplant as Treatment of Choice for End-stage Renal Disease Preemptive Transplant and Transplanting Older Patients: An International Survey [O] . Nasrollah Ghahramani, Zahra Yeganeh Karparvar, Mehrdad Ghahramani, -1

机译：肾病学家对肾移植的看法作为终末期肾病先发制体移植和移植老年患者的选择：国际调查
7. Successful treatment of nephrotic syndrome caused by recurrent IgA nephropathy with chronic active antibody-mediated rejection three years after kidney transplantation [O] . Tatsuhiro Yaginuma, Hiroyasu Yamamoto, Jun Mitome, 2011

机译：肾移植后三年慢性活性抗体介导的慢性活性抗体介导的肾病患者肾病综合征的成功治疗
8. End-Stage Renal Disease: Characteristics of Kidney Transplant Recipients, Frequency of Transplant Failures, and Cost to Medicare [R] . 2007

机译：终末期肾病：肾移植受者的特征，移植失败的频率和医疗保险的成本

Variability in Diagnosis and Treatment of Recurrent IgA Nephropathy in Kidney Transplants: Results of Surveys of Renal Pathologists and Nephrologists

著录项

引文网络

相似文献

相关主题

期刊订阅